4//SEC Filing
Reeth Mark D 4
Accession 0001209191-12-025829
CIK 0001009356other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 5:35 PM ET
Size
5.3 KB
Accession
0001209191-12-025829
Insider Transaction Report
Form 4
Reeth Mark D
Gen Counsel&VP Corp Compliance
Transactions
- Sale
Common Stock
2012-05-01$48.91/sh−1,000$48,910→ 33,668 total
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2011.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.86 to $48.94, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001399353
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 5:35 PM ET
- Size
- 5.3 KB